
Keywords: prostate; prostatic neoplasms; SEER program; risk; trendsADT, androgen deprivation therapy; CCI, Deyo-Charlson comorbidity index; NCDB, National Cancer Database; NCIM, noncurative initial management; NOS, not otherwise specified; PCa, prostate cancer; PSA